Harald Reinhart, Chief Medical Officer at Zai Lab Ltd (ZLAB), sold 10,800 shares at $150.41 ($1.6M) on 2021-09-07, disclosed to the SEC on 2021-09-08.
Open-market sale of $1.6M ZLAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.00 | 100 | $14K | 0.9% |
| 2 | $146.98 | 200 | $29K | 1.8% |
| 3 | $148.69 | 300 | $45K | 2.7% |
| 4 | $150.41 | 2,000 | $301K | 18.4% |
| 5 | $151.28 | 6,600 | $998K | 61.2% |
| 6 | $152.11 | 800 |
| $122K |
| 7.5% |
| 7 | $152.11 | 800 | $122K | 7.5% |
| Total | $151.01 avg | 10,800 | $1.6M | 100% |
| Filing → |
| ZLAB | SELL | 2024-04-03 | $29K | — | Filing → |
| ZLAB | SELL | 2024-01-03 | $251K | — | Filing → |
| ZLAB | SELL | 2023-03-07 | $459K | — | Filing → |